VLP Therapeutics Raises $16 Million Series A Funding For Cancer Treatment Vaccine

VLP Therapeutics, a US-based biopharmaceutical company founded in 2013, announced on Monday that it has secured Series A funding worth $16 million from investors such as MIYAKO Capital and Konishiyasu...